HY-P99496-1mg
|
MedChemexpress LLC
|
Cendakimab [CAS 2151032-62-9]
|
|
COVID-19-immunoregulation
|
|
HY-P99496-10mg
|
MedChemexpress LLC
|
Cendakimab [CAS 2151032-62-9]
|
|
COVID-19-immunoregulation
|
|
HY-P99496-5mg
|
MedChemexpress LLC
|
Cendakimab [CAS 2151032-62-9]
|
|
COVID-19-immunoregulation
|
|
HY-P80627-10uL
|
MedChemexpress LLC
|
Collagen I Alpha 2 Antibody
|
|
|
|
HY-P80627-100uL
|
MedChemexpress LLC
|
Collagen I Alpha 2 Antibody
|
|
|
|
HY-P80627-50uL
|
MedChemexpress LLC
|
Collagen I Alpha 2 Antibody
|
|
|
|
HY-103663-10mg
|
MedChemexpress LLC
|
MAK683 [CAS 1951408-58-4]
|
|
Cancer-programmed cell death
|
|
HY-103663-100mg
|
MedChemexpress LLC
|
MAK683 [CAS 1951408-58-4]
|
|
Cancer-programmed cell death
|
|
HY-103663-25mg
|
MedChemexpress LLC
|
MAK683 [CAS 1951408-58-4]
|
|
Cancer-programmed cell death
|
|
HY-103663-5mg
|
MedChemexpress LLC
|
MAK683 [CAS 1951408-58-4]
|
|
Cancer-programmed cell death
|
|
HY-103663-50mg
|
MedChemexpress LLC
|
MAK683 [CAS 1951408-58-4]
|
|
Cancer-programmed cell death
|
|
HY-103663-1mL
|
MedChemexpress LLC
|
MAK683 [CAS 1951408-58-4] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-P80752-10uL
|
MedChemexpress LLC
|
Mitofusin 2 Antibody
|
|
|
|
HY-P80752-100uL
|
MedChemexpress LLC
|
Mitofusin 2 Antibody
|
|
|
|
HY-P80752-50uL
|
MedChemexpress LLC
|
Mitofusin 2 Antibody
|
|
|
|